Sergliflozin etabonate

Sergliflozin etabonate, a SGLT-2 inhibitor, is used potentially for the treatment of type 2 diabetes and obesity.

408504-26-7

≥ 2 years

>98% (HPLC)

448.468

C23H28O9

Research use only, not for human use.

Protoporphyrinogen oxidase

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

MBS1296772-01 0.02 mg (E-Coli)

Ask

MBS1296772-02 0.02 mg (Yeast)

Ask

MBS1296772-03 0.1 mg (E-Coli)

Ask

MBS1296772-04 0.1 mg (Yeast)

Ask

MBS1296772-05 0.02 mg (Baculovirus)

Ask

MBS1296772-06 0.02 mg (Mammalian-Cell)

Ask